A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors

Summary

This study is a single-arm, open, dose-escalation, and dose-expansion phase I clinical trial of QLS12004 in patients with advanced solid tumors, designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of QLS12004 in subjects with advanced solid tumors.

Timeline

Start

2023-04-17

Primary completion

2024-05-30

Completion

2025-05-30

Drugs

Indications